EICHORCondition: Schizophrenia · Sponsor: Bristol-Myers Squibb
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria * Participants must have a primary diagnosis of schizophrenia established by a comprehensive psychiatric evaluation based on the Diagnostic and Statistical Manual of Mental Disorders⎯Fifth Edition (DSM-5) criteria and confirmed by Mini International Neuropsychiatric Interview (MINI). * Participants must have a PANSS total score between 80 and 120, inclusive. * Participants must have a CGI-S score of ≥ 4. Exclusion Criteria * Participants must not have any primary DSM-5 disorder other than schizophrenia within 12 months before screening. * Participants must not be newly diagnosed or experiencing their first treated episode of schizophrenia. * Participants must not have any history or presence of clinically significant medical conditions. * Other protocol-defined Inclusion/Exclusion criteria apply.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Hotei Hospital | Kōnan, Aichi-ken, Japan | Recruiting |
| Local Institution - 0056 | Nagoya, Aichi-ken, Japan | Not Yet Recruiting |
| Okehazama Hospital | Toyoake, Aichi-ken, Japan | Recruiting |
| Fujita Health University | Toyoake, Aichi-ken, Japan | Recruiting |
| National Kohnodai Medical Center. | Ichikawa, Chiba, Japan | Recruiting |
| National Hospital Organization Shimofusa Psychiatric Medical Center | MIdori-ku, Chiba-shi, Chiba, Japan | Recruiting |
| Local Institution - 0032 | Iizuka, Fukuoka, Japan | Withdrawn |
| Local Institution - 0037 | Kitakyushu, Fukuoka, Japan | Not Yet Recruiting |
| Shiranui Hospital | Omuta, Fukuoka, Japan | Recruiting |
| Takeda General Hospital - Aizuwakamatsu | Aizu-Wakamatsu, Fukushima, Japan | Recruiting |
| Holy Cross Hospital - Toki | Toki, Gifu, Japan | Recruiting |
| Kure Medical Center | Kure, Hiroshima, Japan | Recruiting |
+ 44 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06882785